COVID-19 vaccine manufacturers have been repeating for months: two doses are better than one.The U.S. Centres for Disease Control and Prevention (CDC) study found that a single dose of the Pfizer-BioNTech or Moderna vaccine is 64 per cent effective against hospitalizations in adults over 65 years of age.
That number leaps to 94 per cent at least 14 days after a second dose of the same vaccines.The small-scale study surveyed 417 older adults in 24 hospitals spread across 14 states.Yet it provides more real-world evidence of what had already been proven in clinical trials for both the Pfizer and Moderna vaccines, which found very similar results to the CDC study.
Read more on globalnews.ca